These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 5456856)

  • 1. Rifampicin in the treatment of drug-resistant tuberculosis. A report on 13 patients with pulmonary and one patient with renal disease.
    Engbaek HC; Vergmann B
    Scand J Respir Dis; 1970; 51(1):11-27. PubMed ID: 5456856
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-resistant strains of Mycobacterium tuberculosis isolated in Russia.
    Stepanshina VN; Panfertsev EA; Korobova OV; Shemyakin IG; Stepanshin YG; Medvedeva IM; Dorozhkova IR
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):149-52. PubMed ID: 10091881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A; Raafat H; Siddiqui GM
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract]   [Full Text] [Related]  

  • 4. [Usefulness of rifampicin for pulmonary resection of drug-resistant pulmonary tuberculosis--report of the 13th series study. C].
    Kekkaku; 1973 Jan; 48(1):29-33. PubMed ID: 4632268
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rifampicin in the treatment of patients with chronic destructive tuberculosis complicated by drug intolerance and Mycobacterium drug resistance].
    Adamovich VN; Kolomytseva OS; Gur'ian IE
    Vrach Delo; 1975 Jan; (1):95-9. PubMed ID: 806177
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of chronic tuberculosis patients with ethambutol and protoionamide combined with rifampicin and capreomicin].
    Grassi C; Cornia G; Cirianni C; Garimoldi M; Ginesu F; Mandler F; Perna G; Pradella F
    G Ital Chemioter; 1968; 15(4):92-4. PubMed ID: 5744843
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin in the treatment of resistant pulmonary tuberculosis.
    Wäre M; Lorenzen J
    Scand J Respir Dis Suppl; 1970; 72():113-9. PubMed ID: 4990617
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacteriologic test during rifampicin treatment].
    Ivaldy F
    Rev Tuberc Pneumol (Paris); 1969; 33(6):818-20. PubMed ID: 4989191
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological aspects of adverse reactions during treatment with rifampicin].
    Zeană C; Bănică D; Algeorge G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(1):33-7. PubMed ID: 6264568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rifampicin in the treatment of pulmonary tuberculosis].
    Bumbăcescu N; Ionescu C
    Ftiziologia; 1971; 20(6):619-22. PubMed ID: 5162288
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preliminary clinical observations on the use of Rifampicin in chronic cavitary pulmonary tuberculosis previously treated with and resistant to other drugs].
    Mauro G
    Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):461-6. PubMed ID: 5309059
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 1. A preliminary study. The results of Rifampicin treatment for advanced pulmonary tuberculosis resistant to conventional antituberculous drugs].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):251-6. PubMed ID: 5460317
    [No Abstract]   [Full Text] [Related]  

  • 17. [Late results of treatment of chronic pulmonary tuberculosis with rifampicin].
    Lachowicz E; Polaczek E; Araszkiewicz W; Kozakow H; Pszonicka A; Styszewska H; Janowiec M; Grabowska R
    Gruzlica; 1973 Jul; 41(7):781-7. PubMed ID: 4730979
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience of the treatment of drug-resistant pulmonary tuberculosis with rifampicin combined with ethambutol and capreomycin.
    Wäre M; Heinivaara O; Elo R; Tala E
    Scand J Respir Dis Suppl; 1969; 69():59-63. PubMed ID: 4906375
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug resistant tuberculosis in Estonia.
    Kruuner A; Sillastu H; Danilovitsh M; Levina K; Svenson SB; Källenius G; Hoffner SE
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):130-3. PubMed ID: 9562123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First experience with rifampicin in retreatment of resistant cases.
    Tousek J
    Acta Tuberc Pneumol Belg; 1969; 60(3):478-81. PubMed ID: 5371672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.